Clinical Trial Update: A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the safety and pharmacokinetics of MEHD7945A in participants with locally advanced or metastatic epithelial tumors, sponsored by Genen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Tumors

Drugs mentioned

• MEHD7945A (MEHD7945A)

Snippet

Sponsor: Genentech, Inc. | Conditions: Epithelial Tumors, Malignant | Phase 1 | Status: COMPLETED